Ten-valent pneumococcal conjugate vaccine ( PCV10 ) was earlier shown to reduce clinically suspected , non-laboratory-confirmed invasive pneumococcal disease ( IPD ) in a cluster-randomized trial ( the Finnish Invasive Pneumococcal disease trial ) .